Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antinuclear antibody in systemic sclerosis (scleroderma)

Y Okano1

  • 1Nippon Kokan Hospital, Kawasaki, Japan.

Rheumatic Diseases Clinics of North America
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and feasibility of D3 lymph node dissection in oldest-old patients undergoing colorectal cancer surgery: a multi-institutional, retrospective analysis.

Techniques in coloproctology·2025
Same author

Growth of In <sub></sub> Ga<sub>1-</sub> Sb alloy semiconductor at the International Space Station (ISS) and comparison with terrestrial experiments.

NPJ microgravity·2017
Same author

Takayasu arteritis and ischaemic stroke.

QJM : monthly journal of the Association of Physicians·2015
Same author

Antifungal activity of some substituted selenosemicarbazones and related compounds.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Antifungal activity of beta-nitrostyrenes and some cyclohexane derivatives.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Prospective study of a systemic sclerosis/dermatomyositis overlap patient presenting with anti-Ku and anti-Ki antibodies.

Modern rheumatology·2014
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Autoantibodies to intracellular molecules, particularly antinuclear antibodies (ANAs), are key in diagnosing Systemic Sclerosis (SSc). Identifying specific ANAs like anti-RNA polymerase aids in early SSc detection and understanding disease associations.

Area of Science:

  • Immunology
  • Rheumatology
  • Serology

Background:

  • Autoantibodies to intracellular molecules are characteristic of Systemic Sclerosis (SSc).
  • Sophisticated methods have advanced the identification of novel autoantigens targeted by antinuclear antibodies (ANAs) in SSc patients.
  • Antibodies to RNA polymerases represent a significant SSc-specific ANA, alongside anti-topoisomerase I and anticentromere antibodies.

Purpose of the Study:

  • To highlight the diagnostic utility of ANAs in Systemic Sclerosis.
  • To discuss the immunogenetic factors influencing ANA production in SSc.
  • To explore potential mechanisms of ANA generation, including antigen-driven responses and molecular mimicry.

Main Methods:

  • Analysis of patient sera using advanced immunological techniques.

Related Experiment Videos

  • Characterization of autoantigens targeted by SSc-specific ANAs.
  • Review of existing literature on ANA immunogenetics and pathogenesis.

    • Main Results:

    • Identification of antibodies to RNA polymerases as a major SSc-specific ANA.
    • Ability to identify over 85% of SSc patients through specific ANA detection.
    • Unveiling of an immunogenetic predisposition to ANA synthesis in SSc.

    Conclusions:

    • Specific ANAs, including anti-RNA polymerase antibodies, are valuable diagnostic markers for SSc.
    • The origin of ANAs is likely linked to the underlying causes of SSc.
    • Each SSc-associated ANA is linked to a unique set of clinical manifestations, suggesting a role in disease pathogenesis.